[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_401 

# __Regulatory agencies__

## Category to which it belongs

* [A diverse collection of organizations responsible for various aspects of governance, health, environment, safety, and communication.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_249.md)

## Closest similar item

* [Environmental agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1629.md)
* [Environmental agency](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1293.md)
* [Government agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)
* [Government agency](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1610.md)
* [Government regulators](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_55.md)
* [Regulatory agency](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_737.md)
* [Regulatory authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_683.md)
* [Regulatory authority](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1598.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2372.md)
* [Regulatory body](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2596.md)

## Risk affecting this stakeholder

* [Absence of centralized, sponsor-driven primary data sharing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1253.md)
* [Anticompetitive behaviors associated with concentration in gvcs](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1250.md)
* [Challenges in conducting diagnostic test accuracy systematic review](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5815.md)
* [Identification of drugs with potential anti-coronavirus effects](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6939.md)
* [Inaccurate reference tests](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7934.md)
* [Inconsistencies in accuracy measures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7935.md)
* [Lack of geographical analysis of health and safety violations in certain states](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8204.md)
* [Misuse of antimicrobial particles in paints](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9447.md)
* [Multifaceted reasons for non-data sharing, including unawareness of legal requirements and language barriers](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17237.md)
* [Trends against antimicrobial additives may lead to reduced use of effective materials that can prevent the spread of viruses on surfaces.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17614.md)

## Risks that can be mitigated by this stakeholder

* [Absence of centralized, sponsor-driven primary data sharing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1613.md)
* [Adoption of biosensors for disease surveillance](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1777.md)
* [Air pollution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_148.md)
* [Approval and widespread use of various poct systems](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1114.md)
* [Assumptions on quality assurance for clinical trials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3521.md)
* [Barriers to innovation due to regulatory procedures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3942.md)
* [Bias in favoring large ict corporations in the implementation of smart city products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3982.md)
* [Challenges in conducting diagnostic test accuracy systematic review](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4001.md)
* [Chlorine leakage due to improper handling or storage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4864.md)
* [Data security, encryption, ethics, and regulation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5050.md)
* [Data sharing statements from covid-19 trials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5149.md)
* [Development of makeshift ventilation solutions using off-the-shelf components and 3d printing techniques may pose risks related to device safety, reliability, and function.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5170.md)
* [Drone delivery and robot-powered delivery vehicles may minimize the need for human delivery personnel, reducing the potential for disease transmission through human contact.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5205.md)
* [Exposure to toxic heavy metals in green buildings due to the use of fly ash in construction materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5232.md)
* [Failure to resolve the effects of the polyurethane-only coating, demonstrating the necessity of cu 2 o in the film.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5455.md)
* [Financial subsidies may lead to an increase in the production and distribution of iot devices, potentially increasing the risk of disease transmission through contaminated devices.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5501.md)
* [Fluctuating trends in construction-related complaints over time](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5511.md)
* [High concentration of complaints in specific states](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5693.md)
* [High concentration of inorganic compounds for disinfection](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5796.md)
* [Identification of drugs with potential anti-coronavirus effects](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5798.md)
* [Inadequate fluid barrier and air filtration in non-fda-cleared 3d-printed ppe devices.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5815.md)
* [Inadequate implementation of safety recommendations during the pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5816.md)
* [Incomplete or unverified safety results and solutions for biofiltration technology](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5817.md)
* [Influence of relative humidity on pathogenic bacteria and viruses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6058.md)
* [Infrequent audit and enforcement of data sharing by scientific journals and governing bodies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6059.md)
* [Insufficient testing and approval of medical inventions for disease prevention may lead to ineffective or unsafe products being used in the market](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6765.md)
* [Investigation of new drugs for covid-19 therapy, such as tocilizumab and ace2-targeted treatments, may have unknown side effects and long-term impacts.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6813.md)
* [Irradiating the coronavirus in liquid requires a uv-c dose that is in the region 1.8-6.0 times higher than that required when the virus is suspended in air.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6939.md)
* [Issues related to the development of antiviral coatings and materials](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7126.md)
* [Lack of clarity on pollution prevention measures for air and water](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7128.md)
* [Lack of cognitive trust through untact channels and strong relationships in banking services](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7129.md)
* [Lack of fast and deliberate response to the crisis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7915.md)
* [Lack of geographical analysis of health and safety violations in certain states](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7929.md)
* [Lack of robust testing for innovative technologies and solutions may lead to deployment of unproven or flawed systems, increasing the risk of technological failures and negative impact on public health and safety.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7934.md)
* [Lack of specific ventilation guidelines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7935.md)
* [Lack of standardized method for sars-cov-2 detection in environmental samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8204.md)
* [Lack of standardized testing for uvgi effectiveness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8394.md)
* [Limited awareness of the requirements for social distancing and safety guidelines in physical space modeling](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9447.md)
* [Limited discussion on the perception of workers in the pandemic and the effectiveness of safety measures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9449.md)
* [Low-cost mass production of loc-based devices may lead to compromised quality control and increased risk of device malfunction.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9539.md)
* [Massive availability and utilization of data in urban environments through 6g technology](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9965.md)
* [Misidentification or misinterpretation of clinical trial outcomes by ai, leading to incorrect drug development decisions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10103.md)
* [Misinterpretation of virus sustainability on surfaces](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10408.md)
* [Multifaceted reasons for non-data sharing, including unawareness of legal requirements and language barriers](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10414.md)
* [Off-label use of favipiravir for sars-cov-2 treatment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10436.md)
* [Possible spread of epidemic through air conditioning systems](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11058.md)
* [Potential failure of other coating technologies amine and ammonium-based polymers to inactivate the virus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11344.md)
* [Privacy and security risks with wearable technology data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11345.md)
* [Quality-related concerns over drug efficacy, safety, and surveillance](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11421.md)
* [Quality-related concerns over drug efficacy, safety, and surveillance for malaria prevention](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11842.md)
* [Regulatory approvals and medical device clearance processes may delay the implementation of healthcare technology.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12060.md)
* [Reliance on adult female mosquitoes to disseminate insecticide-auto-dissemination for targeting ae. aegypti.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12788.md)
* [Reliance on wearable technology for health monitoring](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13221.md)
* [Rise of counterfeit products](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13750.md)
* [Risk of sars-cov-2 transmission in food industries due to lack of proper disinfection measures.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13751.md)
* [Risks associated with the use of copper as a virus-inactivating solution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13752.md)
* [Safety concerns](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14020.md)
* [Trends against antimicrobial additives may lead to reduced use of effective materials that can prevent the spread of viruses on surfaces.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14278.md)
* [Uncertainties associated with sample collection and analytical variability](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17336.md)
* [Unregulated promotion of drugs based on information extracted from ontologies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17340.md)
* [Use of disinfectants containing phenolic agents](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17680.md)
* [Use of experimental and unapproved drugs for covid-19 treatment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18062.md)
* [Use of sewage as an indicator of the scale of infection, including covid-19, and the development of waste-based epidemiology wbe methods.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18243.md)
* [Use of surveillance systems and tracking technology for outbreak control and deconfinement process](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18592.md)
* [Using ai algorithms to design new molecules or repurpose drugs may lead to unforeseen side effects or interactions with existing medications.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18993.md)
* [Usurpation of regulatory processes by powerful incumbent interests during the pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19048.md)
* [Wasteful practices and inadequate sanitation in the food sector contribute to the risk of disease transmission and foodborne illnesses, impacting public health.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19336.md)

## This Stakeholder belongs to this Stakeholder Group

* [City officials](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_724.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_9.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Enforcement organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_706.md)
* [Regulatory bodies](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_18.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Enhanced data comparability](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_1007.md)

## This stakeholders can act on the following general blueprint(s)

* [Implementing Wastewater Monitoring and Enhanced Sanitation Measures to Mitigate SARS-CoV-2 Spread](https://github.com/mm80843/T3.5/blob/pages/aBlueprint/PBN__aBlueprint_1.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_0.md)
* [Beneficiary](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_1.md)

